Arrowhead Pharmaceuticals Inc
General ticker "ARWR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.8B
Arrowhead Pharmaceuticals Inc does not follow the US Stock Market performance with the rate: -22.8%.
Estimated limits based on current volatility of 2.1%: low 19.47$, high 20.32$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [14.77$, 32.16$]
- 2025-09-30 to 2026-09-30 estimated range: [12.73$, 27.83$]
Short-term ARWR quotes
Long-term ARWR plot with estimates
Financial data
YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
---|---|---|---|
Operating Revenue | $243.23MM | $240.74MM | $3.55MM |
Operating Expenses | $421.74MM | $445.74MM | $604.63MM |
Operating Income | $-178.51MM | $-205.00MM | $-601.08MM |
Non-Operating Income | $5.80MM | $-1.49MM | $-11.38MM |
Interest Expense | $5.03MM | $18.33MM | $32.35MM |
R&D Expense | $297.31MM | $353.19MM | $505.87MM |
Income(Loss) | $-172.71MM | $-206.49MM | $-612.46MM |
Taxes | $3.79MM | $2.78MM | $-12.97MM |
Profit(Loss) | $-176.49MM | $-209.28MM | $-599.49MM |
Stockholders Equity | $105.96MM | $271.34MM | $185.44MM |
Inventory | $21.61MM | $0.00MM | $0.00MM |
Assets | $691.94MM | $765.55MM | $1,139.80MM |
Operating Cash Flow | $-136.13MM | $-153.89MM | $-462.85MM |
Capital expenditure | $52.78MM | $176.74MM | $141.47MM |
Investing Cash Flow | $-5.42MM | $-96.16MM | $-420.07MM |
Financing Cash Flow | $65.19MM | $253.05MM | $870.52MM |
Earnings Per Share* | $-1.67 | $-1.91 | $-5.00 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.